Stephen L Sabba sold $410K of Ligand Pharmaceuticals Incorporated (LGND)

Executed Mar 3, disclosed Mar 5, 2 days later.

Value, as filed

$410K

2,034 sh × $201.50

Executed

Mar 3

the trade date, as filed

Disclosed

Mar 5

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Stephen L Sabba Director profile →

Stephen L Sabba (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Ligand Pharmaceuticals Incorporated (LGND). The largest single filing was $545K of LGND (2,145 sh × $254.00, as filed), executed Jun 16.

The name

LGND

Ligand Pharmaceuticals Incorporated LGND · Healthcare · 36 filings in 24 months ticker →

Healthcare · Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Stephen L Sabba in LGND

LGNDSALE Ligand Pharmaceuticals Incorporated $545K
2,145 sh × $254.00
Exec Jun 16
Filed Jun 18 · 5:30 PM ET LGNDSALE Ligand Pharmaceuticals Incorporated $208K
1,000 sh × $207.87
Exec Mar 23
Filed Mar 25 · 5:30 PM ET